Russell Investments Group, Ltd.

Position in ALDX — Aldeyra Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in ALDX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$192,450

+$49,985 QoQ

Shares Held

90,353

+7.2% QoQ

Ownership

0.150%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 108 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 76% Shared 0% None 24%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. ALDX ranks #185 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$192,450	90,353	+7.2%	Shares	Defined	2026-08-06
2026-03-31	$142,465	84,300	-26.1%	Shares	Other	2026-05-08
2025-12-31	$591,170	114,126	+2.7%	Shares	Other	2026-02-17
2025-09-30	$579,949	111,102	+321.7%	Shares	Other	2025-11-13
2025-06-30	$100,896	26,344	-2.6%	Shares	Other	2025-08-13
2025-03-31	$155,490	27,042	+274.6%	Shares	Other	2025-05-13
2024-09-30	$38,905	7,218	-54.5%	Shares	Defined	2024-11-13
2021-06-30	$179,931	15,881	-66.1%	Shares	Defined	2021-08-04
2020-12-31	$321,060	46,802	-4.5%	Shares	Sole	2021-02-08
2020-09-30	$363,318	49,031	+16.2%	Shares	Defined	2020-11-09
2020-06-30	$175,989	42,204	—	Shares	Defined	2020-08-05
No filing history on record for this holder in this stock.